The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Sylvie Ménard

Molecular Targeting Unit

Department of Experimental Oncology

Scientific Direction

Istituto Nazionale Tumori

Italy

[email]@istitutotumori.mi.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Molecular Targeting Unit, Department of Experimental Oncology, Scientific Direction, Istituto Nazionale Tumori, Italy. 2001 - 2002
  • The Molecular Targeting Unit, Istituto Nazional Tumori, Milan, Italy. 2001
  • Istituto Nazionale Tumori and Institute of Pathology, University of Milan, Milan, Italy. 2001
  • Division of Experimental Oncology E, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy. 1997 - 2000

References

  1. HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors. Ménard, S., Balsari, A., Casalini, P., Tagliabue, E., Campiglio, M., Bufalino, R., Cascinelli, N. Clin. Cancer Res. (2002) [Pubmed]
  2. Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables. Ménard, S., Valagussa, P., Pilotti, S., Gianni, L., Biganzoli, E., Boracchi, P., Tomasic, G., Casalini, P., Marubini, E., Colnaghi, M.I., Cascinelli, N., Bonadonna, G. J. Clin. Oncol. (2001) [Pubmed]
  3. HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer. Ménard, S., Casalini, P., Campiglio, M., Pupa, S., Agresti, R., Tagliabue, E. Ann. Oncol. (2001) [Pubmed]
  4. HER2 as a prognostic factor in breast cancer. Ménard, S., Fortis, S., Castiglioni, F., Agresti, R., Balsari, A. Oncology (2001) [Pubmed]
  5. Role of HER2 gene overexpression in breast carcinoma. Ménard, S., Tagliabue, E., Campiglio, M., Pupa, S.M. J. Cell. Physiol. (2000) [Pubmed]
  6. Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model. Ménard, S., Aiello, P., Tagliabue, E., Rumio, C., Lollini, P.L., Colnaghi, M.I., Balsari, A. Cancer Res. (2000) [Pubmed]
  7. Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors. Ménard, S., Casalini, P., Tomasic, G., Pilotti, S., Cascinelli, N., Bufalino, R., Perrone, F., Longhi, C., Rilke, F., Colnaghi, M.I. Breast Cancer Res. Treat. (1999) [Pubmed]
  8. The 67 kDa laminin receptor as a prognostic factor in human cancer. Ménard, S., Tagliabue, E., Colnaghi, M.I. Breast Cancer Res. Treat. (1998) [Pubmed]
  9. New insights into the metastasis-associated 67 kD laminin receptor. Ménard, S., Castronovo, V., Tagliabue, E., Sobel, M.E. J. Cell. Biochem. (1997) [Pubmed]
 
WikiGenes - Universities